Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
Toward Rhenium-Based Circularly Polarized OLEDs Using Tailored Chiral Re(CO)3 Emitters.
Davydova MP, Xu T, Agafontsev AM, Meng L, Wolff M, Petyuk MY, Bagryanskaya IY, Berezin AS, Tkachev AV, Meng H, Artem'ev AV. Davydova MP, et al. Among authors: tkachev av. Angew Chem Int Ed Engl. 2024 Dec 16:e202419788. doi: 10.1002/anie.202419788. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39676563
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Screening for depression in the general population through lipid biomarkers.
Tkachev A, Stekolshchikova E, Golubova A, Serkina A, Morozova A, Zorkina Y, Riabinina D, Golubeva E, Ochneva A, Savenkova V, Petrova D, Andreyuk D, Goncharova A, Alekseenko I, Kostyuk G, Khaitovich P. Tkachev A, et al. EBioMedicine. 2024 Dec;110:105455. doi: 10.1016/j.ebiom.2024.105455. Epub 2024 Nov 20. EBioMedicine. 2024. PMID: 39571307 Free PMC article.
143 results